Suppr超能文献

中枢黑皮质素能通路对血压的调节

Modulation of blood pressure by central melanocortinergic pathways.

作者信息

Greenfield Jerry R, Miller Jeffrey W, Keogh Julia M, Henning Elana, Satterwhite Julie H, Cameron Gregory S, Astruc Beatrice, Mayer John P, Brage Soren, See Teik Choon, Lomas David J, O'Rahilly Stephen, Farooqi I Sadaf

机构信息

University of Cambridge Metabolic Research Laboratories, Addenbrooke's Hospital, Cambridge, United Kingdom.

出版信息

N Engl J Med. 2009 Jan 1;360(1):44-52. doi: 10.1056/NEJMoa0803085. Epub 2008 Dec 17.

Abstract

BACKGROUND

Weight gain and weight loss are associated with changes in blood pressure through unknown mechanisms. Central melanocortinergic signaling is implicated in the control of energy balance and blood pressure in rodents, but there is no information regarding such an association with blood pressure in humans.

METHODS

We assessed blood pressure, heart rate, and urinary catecholamines in overweight or obese subjects with a loss-of-function mutation in MC4R, the gene encoding the melanocortin 4 receptor, and in equally overweight control subjects. We also examined the effects of an MC4R agonist administered for 7 days in 28 overweight or obese volunteers.

RESULTS

The prevalence of hypertension was markedly lower in the MC4R-deficient subjects than in the control subjects (24% vs. 53%, P=0.009). After the exclusion of subjects taking antihypertensive medications, blood-pressure levels were significantly lower in MC4R-deficient subjects than in control subjects, with mean (+/-SE) systolic blood pressures of 123+/-14 mm Hg and 131+/-12 mm Hg, respectively (P=0.02), and mean diastolic blood pressures of 73+/-10 mm Hg and 79+/-7 mm Hg, respectively (P=0.03). As compared with control subjects, MC4R-deficient subjects had a lower increase in heart rate on waking (P=0.007), a lower heart rate during euglycemic hyperinsulinemia (P<0.001), and lower 24-hour urinary norepinephrine excretion (P=0.04). The maximum tolerated daily dose of 1.0 mg of the MC4R agonist led to significant increases of 9.3+/-1.9 mm Hg in systolic blood pressure and of 6.6+/-1.1 mm Hg in diastolic blood pressure (P<0.001 for both comparisons) at 24 hours, as compared with placebo. Differences in blood pressure were not explained by changes in insulin levels; there were no significant adverse events.

CONCLUSIONS

Results of our genetic and pharmacologic studies implicate melanocortinergic signaling in the control of human blood pressure through an insulin-independent mechanism.

摘要

背景

体重增加和体重减轻与血压变化有关,但其机制尚不清楚。中枢黑皮质素能信号传导与啮齿动物的能量平衡和血压控制有关,但尚无关于其与人类血压关联的信息。

方法

我们评估了携带黑皮质素4受体(MC4R)功能丧失突变的超重或肥胖受试者以及体重同样超重的对照受试者的血压、心率和尿儿茶酚胺。我们还在28名超重或肥胖志愿者中研究了给予MC4R激动剂7天的效果。

结果

MC4R缺陷受试者的高血压患病率显著低于对照受试者(24%对53%,P = 0.009)。排除服用抗高血压药物的受试者后,MC4R缺陷受试者的血压水平显著低于对照受试者,收缩压平均(±标准误)分别为123±14 mmHg和131±12 mmHg(P = 0.02),舒张压平均分别为73±10 mmHg和79±7 mmHg(P = 0.03)。与对照受试者相比,MC4R缺陷受试者醒来时心率升高幅度较小(P = 0.007),在正常血糖高胰岛素血症期间心率较低(P < 0.001),24小时尿去甲肾上腺素排泄量较低(P = 0.04)。与安慰剂相比,1.0 mg MC4R激动剂的最大耐受日剂量在24小时时导致收缩压显著升高9.3±1.9 mmHg,舒张压显著升高6.6±1.1 mmHg(两项比较P均< 0.001)。血压差异不能用胰岛素水平变化来解释;未发生明显不良事件。

结论

我们的遗传和药理学研究结果表明,黑皮质素能信号传导通过非胰岛素依赖机制参与人类血压控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验